R&D SMEs at risk due to tax credit scheme change
The aim is to prevent fraud, but analysis by the BIA shows the measure will have unintended consequences for life science companies.
Read More
Tag: SME
Catapult offers UK SMEs high-resolution analysis
Medicines Discovery Catapult is inviting UK SMEs working in medicines development to work together on high-resolution analysis of potential drug targets.
Read More
- European life sciences coalition launched to boost investment ecosystem
- 99mtc‑maraciclatide granted fast track status for ILD imaging
- Bioxytran reports rapid viral clearance in phase 2 trial
- Thx Pharma and Biocodex sign rare disease licensing deal
- AstraZeneca bladder cancer therapy wins NICE backing
